Syros Pharmaceuticals Shares Down 62.5% at $1.88 Premarket After Interim Data Shows Co's Rare Blood Cancer Therapy Unlikely to Suceed in Study
syros pharmaceuticals的罕見血液癌症治療方案新數據顯示不能成功,盤前股價暴跌62.5%,跌至1.88美元。
Syros Pharmaceuticals Shares Down 62.5% at $1.88 Premarket After Interim Data Shows Co's Rare Blood Cancer Therapy Unlikely to Suceed in Study
syros pharmaceuticals的罕見血液癌症治療方案新數據顯示不能成功,盤前股價暴跌62.5%,跌至1.88美元。
譯文內容由第三人軟體翻譯。